Karyopharm Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Karyopharm Therapeutics's balance sheet done over the years? Its assets were worth $240,438,000 last year, which is less than in the previous period. 157% of Karyopharm Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $376,644,000, which means an increase by 0% compared compared to last year.
Debt to Assets
| 2014 | 220337000 | 13.54M | 6.15% |
|---|---|---|---|
| 2015 | 215443000 | 17.07M | 7.93% |
| 2016 | 180385000 | 18.14M | 10.06% |
| 2017 | 180294000 | 50.83M | 28.19% |
| 2018 | 341192000 | 158.02M | 46.31% |
| 2019 | 294963000 | 245.18M | 83.13% |
| 2020 | 313050000 | 262.50M | 83.85% |
| 2021 | 305305000 | 384.97M | 126.1% |
| 2022 | 358172000 | 374.82M | 104.65% |
| 2023 | 240438000 | 376.64M | 156.65% |
KPTI Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 52.23M | 135.18M | 190.45M | 85.91M | 128.85M | 118.02M | 68.99M | 49.66M | 58.35M | 150.60M |
Short term investments | 139.21M | 142.77M | 38.15M | 163.32M | 133.09M | 210.17M | 77.47M | 79.88M | 117.27M | 55.11M |
Net receivables | 26.96M | 47.08M | 22.49M | 12.88M | 7.86M | 0 | 0 | 0 | 0 | 0 |
Inventory | 3.04M | 4.22M | 4.10M | 2.64M | 346K | 0 | 0 | 0 | 0 | 0 |
Other current assets | 12.47M | 19.82M | 2.88M | 559K | 1.48M | 6.41M | 3.70M | 2.08M | 3.93M | 4.05M |
Total current assets | 233.92M | 326.75M | 258.09M | 289.53M | 273.66M | 334.61M | 148.42M | 131.63M | 177.6M | 207.75M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 4.88M | 7.37M | 1.64M | 2.21M | 3.04M | 3.86M | 2.18M | 2.83M | 3.48M | 2.75M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 633K | 637K | 24.21M | 2.01M | 2.00M | 29.39M | 45.43M | 33.87M | 8.65M |
Other non-current assets | 1.63M | 23.41M | 44.92M | -2.92M | 16.23M | 716K | 290K | 479K | 482K | 1.17M |
Total non-current assets | 6.51M | 31.42M | 47.20M | 23.51M | 21.29M | 6.58M | 31.87M | 48.74M | 37.84M | 12.58M |
Total assets | 240.43M | 358.17M | 305.30M | 313.05M | 294.96M | 341.19M | 180.29M | 180.38M | 215.44M | 220.33M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 69.12M | 297K | 2.34M | 9.36M | 21.92M | 0 | 206K | 0 |
Short term debt | 6.61M | 2.87M | 2.31M | 1.91M | 1.64M | 32.88M | 0 | 0 | 0 | 0 |
Total current liabilities | 69.47M | 65.90M | 73.71M | 297K | 46.35M | 46.90M | 49.46M | 16.47M | 15.13M | 12.30M |
| Non-current liabilities: | ||||||||||
Long term debt | 173.70M | 170.10M | 169.29M | 117.92M | 109.85M | 102.66M | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 133.45M | 204.72M | 215.68M | 144.27M | 57.21M | 97.42M | 1.36M | 1.66M | 0 | 1.24M |
Total non-current liabilities | 307.16M | 374.82M | 384.97M | 262.20M | 245.18M | 111.11M | 1.36M | 1.66M | 1.94M | 1.24M |
Total liabilities | 376.64M | 374.82M | 384.97M | 262.50M | 245.18M | 158.02M | 50.83M | 18.14M | 17.07M | 13.54M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |